These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16168925)

  • 1. Pathological gambling in Parkinson's disease.
    Stocchi F
    Lancet Neurol; 2005 Oct; 4(10):590-2. PubMed ID: 16168925
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine agonists, sleep disorders, and driving in Parkinson's disease.
    Uitti RJ; Wszolek ZK
    Adv Neurol; 2003; 91():343-9. PubMed ID: 12442692
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
    Klos KJ; Bower JH; Josephs KA; Matsumoto JY; Ahlskog JE
    Parkinsonism Relat Disord; 2005 Sep; 11(6):381-6. PubMed ID: 16109498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramipexole, ropinirole, and mania in Parkinson's disease.
    Singh A; Althoff R; Martineau RJ; Jacobson J
    Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.
    Driver-Dunckley E; Samanta J; Stacy M
    Neurology; 2003 Aug; 61(3):422-3. PubMed ID: 12913220
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical hazards of the internet: gambling in Parkinson's disease.
    Larner AJ
    Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
    [No Abstract]   [Full Text] [Related]  

  • 7. Compulsive behaviors in patients with Parkinson's disease.
    Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
    Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Punding in Parkinson's disease.
    O'Sullivan SS; Evans AH; Lees AJ
    Pract Neurol; 2007 Nov; 7(6):397-9. PubMed ID: 18024780
    [No Abstract]   [Full Text] [Related]  

  • 9. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
    Grosset K; Needleman F; Macphee G; Grosset D
    Mov Disord; 2004 Nov; 19(11):1370-4. PubMed ID: 15389984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pramipexole and ropinirole for Parkinson's disease.
    Med Lett Drugs Ther; 1997 Nov; 39(1014):109-10. PubMed ID: 9398824
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Parkinson's disease--where do we go from here?
    Suchowersky O
    Nat Clin Pract Neurol; 2006 Sep; 2(9):461. PubMed ID: 16932605
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.
    Ahlskog JE
    Physiol Behav; 2011 Jul; 104(1):168-72. PubMed ID: 21557955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of parkinsonism and legal capacity].
    Wallesch CW
    Fortschr Neurol Psychiatr; 2011 Aug; 79(8):441. PubMed ID: 21809256
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity.
    Kulisevsky J; Pagonabarraga J; Martinez-Corral M
    J Neurol; 2009 May; 256(5):816-9. PubMed ID: 19240966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dopamine agonist is effective in Parkinson disease not only against tremor. Depression is also improved].
    MMW Fortschr Med; 2002 May; Suppl 2():88. PubMed ID: 12070869
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
    Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
    J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep attacks in Parkinson's disease.
    Pirker W; Happe S
    Lancet; 2000 Aug; 356(9229):597-8. PubMed ID: 10950264
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arguments in favor of early treatment of Parkinson's disease with dopaminergic agonists].
    Rascol O
    Rev Neurol (Paris); 1999 Jan; 155(1):35-42. PubMed ID: 10093846
    [No Abstract]   [Full Text] [Related]  

  • 19. Sleep attacks--facts and fiction: a critical review.
    Homann CN; Wenzel K; Suppan K; Ivanic G; Crevenna R; Ott E
    Adv Neurol; 2003; 91():335-41. PubMed ID: 12442691
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine agonists and therapy compliance.
    Grosset D
    Neurol Sci; 2008 Dec; 29 Suppl 5():S375-6. PubMed ID: 19381766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.